PharmaReports: Cancer Immunotherapy
LeadDiscovery offers full reports in selected areas of the pharmaceutical and biotech sector.
Each of the reports below has been especially selected by LeadDiscovery. Browse the reports or try our search engine.
This channel is dedicated to immunotherapy approaches to cancer such as interleukins and other immunostimulators. Oncolytic viruses and cell based therapies are also included in this channel. Most reports included in this channel are technological in approach.
Showing results 1 - 50 of 125
- The Emerging Cancer Vaccine Market
- Cancer Stem Cells: Emerging Therapeutic, Diagnostics and Market Opportunities
- Drug Delivery in Cancer - technologies, markets and companies
- Cell Therapy - Technologies, Markets and Companies
- Cancer Diagnostic Testing World Markets
- Cancer Therapeutics Markets
- Therapeutic Monoclonal Antibodies, 2006-2011
- World market for cancer vaccines 2007-2012
- Pipeline Insight: Hematological Malignancies - Pursuit for the next blockbuster intensifies
- Early Toxicology: Markets and Approaches
- Melanoma - Lucrative commercial opportunities persist
- Therapeutic Cancer Vaccines - A turbulent path from bench to bedside
- Gynecological Cancers - Niche opportunities in advanced disease
- Non-Small Cell Lung Cancer
- Biotech Drug Delivery Systems - Key Company Intelligence & Market Outlook to 2012
- Colorectal Cancer - Shaping the future dynamics of colorectal cancer management
- Molecular Targeted Cancer Therapies - More drugs on the market, more targets in the pipeline
- Supportive Care in Cancer Treatment - Some first-generation products proving difficult to dislodge
- Pipeline Insight: Breast Cancer - A diverse and increasingly crowded pipeline
- Pipeline Insight: Cancer Overview Emerging Therapeutic and Commercial Opportunities
- From Blockbuster to Nichebuster
- Commercial Insight Top 20 Cancer Therapeutics
- Ovarian Cancer: Growing importance as secondary indication for targeted therapies
- Monoclonal Antibodies 2007
- The Global Protein Therapeutics Market
- Cancer Therapeutics 2006
- Biogenerics
- Cancer Vaccines Measuring Market Potential
- Acute Leukemias - Persistent unmet needs confer significant commercial opportunity
- Gastric Cancer - Targeted Therapies Home In On a Neglected Tumor Type
- Preclinical Cancer Therapeutics 2007
- Chemotherapy Market Insights, 2006-2016
- Renal Cell Carcinoma - Novel Targeted Treatments to Fill the Void
- Therapeutic Vaccines
- Biogenerics 2005: A New Level of Complexity
- Myelodysplastic Syndrome - An underserved population offers commercial opportunity
- Stakeholder Insight: Prostate Cancer
- Chronic Leukemias - Curative Intent Raises the Bar
- Innovative Targeted Oncology Therapies
- Optimizing Targeted Treatment in Cancer: Negotiating the Challenges to Success
- Pipeline Insight: Hematological malignancies - Targeted treatments & immunotherapy
- Monoclonal Antibody Therapies: Evolving into a $30 billion market
- Breast Cancer - Changing Treatment Paradigms for Local and Locally Advanced Breast Cancer
- Pipeline Insight: Cancer Vaccines and Cell Therapies
- Cancer Market Top 20 Drugs - Supportive Care Grows the Cancer Market
- Cancer Biomarkers: Enhancing diagnostic, therapeutic and developmental strategies
- Non-Small Cell Lung Cancer - Angiogenesis and signal transduction inhibitors to expand market
- Monoclonal Antibodies: Financial and strategic analysis of the mAb market
- Hepatocellular Carcinoma - Opportune indication for novel therapies
- Supportive Care in Oncology-Significant growth opportunities in new supportive care indications
Browse our theraputic areas for other entries:
- Oncology
- Cancer Immunotherapy
- Immunology & Inflammatory Diseases
- Infectious Diseases
- Psychiatric, Addictive & Sleep Disorders
- Pain
- Neurodegenerative & Neuroelectrophysiological Disorders
- Metabolic & Hormonal Disorders
- Cardiovascular Disorders
- GenitoUrinary Tract Disorders
- Technology
- Diagnostics & Devices
- Other Theraputic Areas, Pharmaceutical Strategy and Development